Are isothiocyanates potential anti-cancer drugs?

被引:0
|
作者
Xiang Wu
Qing-hua Zhou
Ke Xu
机构
[1] Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenviroment,
[2] Tianjin Lung Cancer Institute,undefined
[3] Tianjin Medical University General Hospital,undefined
来源
关键词
isothiocyanate; chemoprevention; anticarcinogenic; antitumor; apoptosis; cell cycle;
D O I
暂无
中图分类号
学科分类号
摘要
Isothiocyanates are naturally occurring small molecules that are formed from glucosinolate precursors of cruciferous vegetables. Many isothiocyanates, both natural and synthetic, display anticarcinogenic activity because they reduce activation of carcinogens and increase their detoxification. Recent studies show that they exhibit anti-tumor activity by affecting multiple pathways including apoptosis, MAPK signaling, oxidative stress, and cell cycle progression. This review summarizes the current knowledge on isothiocyanates and focuses on their role as potential anti-cancer agents.
引用
收藏
页码:501 / 512
页数:11
相关论文
共 50 条
  • [1] Are isothiocyanates potential anti-cancer drugs?
    Wu, Xiang
    Zhou, Qing-hua
    Xu, Ke
    [J]. ACTA PHARMACOLOGICA SINICA, 2009, 30 (05) : 501 - 512
  • [2] Anthelmintics as Potential Anti-Cancer Drugs?
    Heo, Dae Seog
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2020, 35 (06)
  • [3] Xanthone derivatives as potential anti-cancer drugs
    Lin, CN
    Liou, SJ
    Lee, TH
    Chuang, YC
    Won, SJ
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1996, 48 (05) : 539 - 544
  • [4] Anti-galectin compounds as potential anti-cancer drugs
    Ingrassia, Laurent
    Camby, Isabelle
    Lefranc, Florence
    Mathieu, Veronique
    Nshimyumukiza, Prosper
    Darro, Francis
    Kiss, Robert
    [J]. CURRENT MEDICINAL CHEMISTRY, 2006, 13 (29) : 3513 - 3527
  • [5] Anti-cancer Potential of Phytoflavonoidal Drugs against Gynecological Cancer
    Sangwan, Kavita
    Goyal, Parveen Kumar
    [J]. CURRENT CANCER THERAPY REVIEWS, 2024,
  • [6] Anti-Cancer Potential of Some Commonly Used Drugs
    Kumari, Pallavi
    Dang, Shweta
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2021, 27 (45) : 4530 - 4538
  • [7] Heteroaryl substituted titanocenes as potential anti-cancer drugs
    Sweeney, Nigel
    Gallagher, William M.
    Mueller-Bunz, Helge
    Pampillon, Clara
    Strohfeldt, Katja
    Tacke, Matthias
    [J]. JOURNAL OF INORGANIC BIOCHEMISTRY, 2006, 100 (09) : 1479 - 1486
  • [8] Selected organotin polyethers as potential anti-cancer drugs
    Shahi, Kim
    Roner, Michael R.
    Carraher, Charles E., Jr.
    Barot, Girish
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 231
  • [9] Anti-cancer drugs
    Bergmann-Leitner, ES
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (09) : 1077 - 1078
  • [10] Anti-cancer drugs
    Bergmann-Leitner, Elke
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (11) : 1048 - 1048